Drug cuts risk of breast cancer recurrence for some early-st

A drug used in people in the early stage of the most common kind of breast cancer – HR+/HER2- breast cancer – significantly reduced the risk of the cancer returning

Related Keywords

Ohio , United States , Chicago , Illinois , American , Anupama Goel , Shreeram Aradhye , Sara Tolaney , Dennisj Slamon , Alberto Montero , Jonsson Comprehensive Cancer Center , Discovery Company , Uh Seidman Cancer Center , Translational Research In Oncology , Drug Administration , Dana Farber Cancer Institute , Cnn , Novartis , Warner Bros , American Society Of Clinical Oncology , Mount Sinai Tisch Cancer Center , Case Western Reserve University School Of Medicine , Cable News Network Inc , American Society , Clinical Oncology , Comprehensive Cancer Center , Cancer Center , Case Western Reserve University School , News Network , Health ,